Big players are eyeing integration and interoperability: We unpack some developments from this year’s CES and where we see the market moving this year.
A group of senators sent a letter to Synchrony and Wells Fargo about their credit cards designed for medical expenses.
Which companies are and aren’t threatening health systems? Incumbent providers should be keeping tabs on retail and tech conglomerates instead of telehealth-focused players.
How healthcare providers will approach telehealth in 2023: Here’s the current status of health systems’ and physician practices’ virtual care programs and how they plan to improve this year.
Telehealth apps are violating consumer trust: We unpack data from STAT’s recent report on direct-to-consumer telehealth companies’ shady data-sharing practices that could eroder consumers’ trust in digital health.
What were Big Tech healthcare players up to in 2022? We review the most prominent healthcare developments from Big Tech entities in the past year and preview what’s on deck for 2023.
Big retail players jockey for healthcare positioning: We look back at noteworthy advancements made by retail health companies this year and how the top players stack up going into 2023.
Consumers want a one-stop-shop health management platform: But will diverse healthcare stakeholders band together to bring such a solution to market?
Reimbursement barriers impede remote patient monitoring growth: Health systems must prove their remote monitoring programs are effective—especially if they want state Medicaid programs to provide coverage.
One healthcare prediction we got wrong for 2022: We look back over the year to see what didn’t happen, per our 2021 prognoses.
Healthcare predictions we got right for 2022: As we expected, the lines between healthcare and retail blurred, and consumers cozied up with connected health devices. We detail other predictions we got right for the year.
Disruption in the digital pharmacy space: We unpack developments with Medly, NowRx, and Mark Cuban Cost Plus Drugs and look ahead to what’s in store for 2023.
Easy access and short wait times drive consumers to telehealth: But virtual care providers will need to stay on top of their game to keep patients from going elsewhere.
Separating the winners and losers among digital health startups: VC investors have a grim outlook on startup valuations—here's how their business strategies might shift to secure funding in 2023.
Good Measures launches prescription food delivery powered by Instacart: We unpack how health systems, health plans, and grocers are getting behind the food as medicine trend.
Convenience > loyalty drives where consumers get care: Our new forecast highlights where patients are getting care now and in the future, and which trends are driving that shift.
Telemental health consolidation is coming: Amwell makes a second bid for Talkspace. We think it foreshadows a bigger trend for struggling telemental companies in 2023.
Cleveland Clinic charges for patient-provider messaging: We unpack the health system’s controversial move and examine if other provider organizations could follow suit.
Walmart Health lost its top executive to JP Morgan: The move doesn’t bode well for the retailer’s health clinic program.
On today's episode, we discuss why the US healthcare system is so fragmented, how an app could save the day, and whether the US will ever be able to synchronize its health services. "In Other News," we talk about the deal to buy multispecialty physician group Summit Health and what to expect from Amazon Clinic. Tune in to the discussion with our analysts Lisa Phillips and Rajiv Leventhal.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844